Bio-active Compounds (Curcumin, Allicin and Gingerol) of Common Spices used in Indian and South-east Asian Countries Might Protect against COVID-19 Infection: A Short Review

References (53)

1. 1 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [DOI]
2. 2 Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 [DOI]
3. 3 Bioavailability of Curcumin: Problems and Promises [DOI]
4. 4 Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target [DOI]
5. 5 Antiviral Actions of Interferons [DOI]
6. 6 ANTIOXIDANT AND ANTI-INFLAMMATORY PROPERTIES OF CURCUMIN [DOI]
7. 7 Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach [DOI]
8. 8 Turmeric and curcumin: Biological actions and medicinal applications
9. 9 ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia [DOI]
10. 10 Emerging coronaviruses: Genome structure, replication, and pathogenesis [DOI]
11. 11 Curcumin nanoformulations: a future nanomedicine for cancer [DOI]
12. 12 Traditional Chinese medicine for COVID-19 treatment [DOI]
13. 13 Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus [DOI]
14. 14 Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments [DOI]
15. 15 Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds [DOI]
16. 16 CURCUMIN INHIBITION OF INFLAMMATORY CYTOKINE PRODUCTION BY HUMAN PERIPHERAL BLOOD MONOCYTES AND ALVEOLAR MACROPHAGES [DOI]
17. 17 Anti-infective Properties of the Golden Spice Curcumin [DOI]
18. 18 Going global – Travel and the 2019 novel coronavirus [DOI]
19. 19 An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study [DOI]
20. 20 Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding [DOI]
21. 21 Adaptive Value of High Mutation Rates of RNA Viruses: Separating Causes from Consequences [DOI]
22. 22 Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil [DOI]
23. 23 Potential effects of curcumin in the treatment of COVID ‐19 infection [DOI]
24. 24 Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review [DOI]
25. 25 Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients [DOI]
26. 26 Antiviral potential of curcumin [DOI]
27. 27 Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin [DOI]
28. 28 Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor [DOI]
29. 29 Covid-19 and Immunity in Aging Populations — A New Research Agenda [DOI]
30. 30 Curcumin as an Antiviral Agent [DOI]
31. 31 Inhibition of Enveloped Viruses Infectivity by Curcumin [DOI]
32. 32 The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family [DOI]
33. 33 Effects of Ginger and Its Constituents on Airway Smooth Muscle Relaxation and Calcium Regulation [DOI]
34. 34 Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes [DOI]
35. 35 Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach [DOI]
36. 36 The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem [DOI]
37. 37 Genomic and proteomic mutation landscapes of SARS‐CoV‐2 [DOI]
38. 38 Inhibition of dengue virus by curcuminoids [DOI]
39. 39 Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats [DOI]
40. 40 Differential mortality in COVID-19 patients from India and western countries [DOI]
41. 41 Recent Developments in Anti-Severe Acute Respiratory Syndrome Coronavirus Chemotherapy [DOI]
42. 42 Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections.
43. 43 Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases [DOI]
44. 44 Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study [DOI]
45. 45 Improving the Anticancer Activity of Curcumin Using Nanocurcumin Dispersion in Water [DOI]
46. 46 Curcumin, an Active Constituent of Turmeric Spice: Implication in the Prevention of Lung Injury Induced by Benzo(a) Pyrene (BaP) in Rats [DOI]
47. 47 Screening of Potent Inhibitors Against 2019 Novel Coronavirus (Covid-19) from Alliumsativum and Allium cepa: An In Silico Approach [DOI]
48. 48 Effect of Allium cepa and Allium sativum on some immunological cells in rats [DOI]
49. 49 Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection [DOI]
50. 50 Catechin and Curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane: insights from Computational study and implication for intervention [DOI]
51. 51 Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
52. 52 Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant [DOI]
53. 53 An Investigation into the Identification of Potential Inhibitors of SARS-CoV-2 Main Protease Using Molecular Docking Study [DOI]

Cited by 15

Showing 7 of 15 known citations — external sources report more than can currently be individually listed.

Related research

• Covid-2019:“A Microbiological Monster” — shares topic coverage
• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
• Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage